These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 22236938)
1. Efficacy of utilising patient self-report of auditory complaints to monitor aminoglycoside ototoxicity. Ramma LD; Ibekwe TS Int J Tuberc Lung Dis; 2012 Feb; 16(2):283. PubMed ID: 22236938 [No Abstract] [Full Text] [Related]
2. [Experimental investigations of the ototoxicity of aminoglycoside antibiotics and their clinical importance (author's transl)]. Federspil P Laryngol Rhinol Otol (Stuttg); 1981 Oct; 60(10):553-7. PubMed ID: 7345286 [TBL] [Abstract][Full Text] [Related]
3. Symptom reporting compared with audiometry for the detection of cochleotoxicity in patients on long-term aminoglycoside therapy. Palmay L; Walker SA; Walker SE; Simor AE Ann Pharmacother; 2011 May; 45(5):590-5. PubMed ID: 21521861 [TBL] [Abstract][Full Text] [Related]
4. The importance of audiometric monitoring in patients with multidrug-resistant tuberculosis. Vasconcelos KA; Frota SMMC; Ruffino-Netto A; Kritski AL Rev Soc Bras Med Trop; 2017; 50(5):646-651. PubMed ID: 29160511 [TBL] [Abstract][Full Text] [Related]
5. [Aminoglycosides, their ototoxic effect]. de la Rosa-Gálvez A; Jáuregui-Renaud K; Hernández-Goribar M Gac Med Mex; 1998; 134(6):705-11. PubMed ID: 9927776 [TBL] [Abstract][Full Text] [Related]
6. Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis. de Jager P; van Altena R Int J Tuberc Lung Dis; 2002 Jul; 6(7):622-7. PubMed ID: 12102302 [TBL] [Abstract][Full Text] [Related]
7. Clinical predictors of aminoglycoside-induced ototoxicity in drug-resistant Tuberculosis patients on intensive therapy. Sogebi OA; Adefuye BO; Adebola SO; Oladeji SM; Adedeji TO Auris Nasus Larynx; 2017 Aug; 44(4):404-410. PubMed ID: 27832910 [TBL] [Abstract][Full Text] [Related]
8. Sequential analysis as a tool for detection of amikacin ototoxicity in the treatment of multidrug-resistant tuberculosis. Vasconcelos KA; Frota SMMC; Ruffino-Netto A; Kritski AL J Bras Pneumol; 2018 Apr; 44(2):85-92. PubMed ID: 29791559 [TBL] [Abstract][Full Text] [Related]
9. [Is it possible to recognize aminoglycoside ototoxicity early using evoked potentials?]. Pechère JC; Bernard P Ann Med Interne (Paris); 1980; 131(6):329-30. PubMed ID: 7469233 [No Abstract] [Full Text] [Related]
10. Adverse outcome pathway for aminoglycoside ototoxicity in drug-resistant tuberculosis treatment. Hong H; Dooley KE; Starbird LE; Francis HW; Farley JE Arch Toxicol; 2019 May; 93(5):1385-1399. PubMed ID: 30963202 [TBL] [Abstract][Full Text] [Related]
11. Otoacoustic emissions: an approach for monitoring aminoglycoside-induced ototoxicity. Hotz MA; Harris FP; Probst R Laryngoscope; 1994 Sep; 104(9):1130-4. PubMed ID: 8072361 [TBL] [Abstract][Full Text] [Related]
14. Investigation of mitochondrial sequence variants associated with aminoglycoside-induced ototoxicity in South African TB patients on aminoglycosides. Human H; Hagen CM; de Jong G; Harris T; Lombard D; Christiansen M; Bardien S Biochem Biophys Res Commun; 2010 Mar; 393(4):751-6. PubMed ID: 20171168 [TBL] [Abstract][Full Text] [Related]